Clinical trial
EMD 128130 for the Treatment of Parkinson's Disease
NCT00009048 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed
Key facts
| NCT number | NCT00009048 |
|---|---|
| Title | EMD 128130 for the Treatment of Parkinson's Disease |
| Official title | Effect of Serotoninergic Treatment in Parkinson's Disease |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Parkinson's Disease |
| Intervention type | Drug |
| Interventions | EMD 128130, IV Levodopa |
| Enrollment | 30 |
| Start date | Jan 1, 2001 |
| Completion | Dec 1, 2003 |
| First posted | Jan 24, 2001 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: